Related Experiment Video
Updated: Jul 31, 2026

A Modified In vitro Invasion Assay to Determine the Potential Role of Hormones, Cytokines and/or Growth Factors in Mediating Cancer Cell Invasion
Published on: April 24, 2015
Signaling mechanisms that mediate invasion in prostate cancer cells
L Bonaccorsi1, S Marchiani, M Muratori
1Dipartimento di Fisiopatologia Clinica (Unità di Andrologia), University of Florence, Italy.
Abstract:
Recent evidence indicates that androgen-sensitive prostate cancer cells have a less malignant phenotype characterized by reduced migration and invasion. We investigated whether the presence of the androgen receptor could affect EGFR-mediated signaling by evaluating autotransphosphorylation of the receptor as well as activation of the downstream signaling pathway PI3K/AKT. Immunoprecipitation studies demonstrated a reduction of EGF-induced tyrosine phosphorylation of EGFR in PC3-AR cells. In addition, EGF-stimulated PI3K activity, a key signaling pathway for invasion of these cells, was decreased in PC3-AR cells and further reduced by treatment with R1881, indicating decreased functionality of EGFR. Our results suggest that the expression of androgen receptors by transfection in PC3 cells confers a less malignant phenotype by interfering with EGFR autophosphorylation and signaling leading to invasion in response to EGF. We used the selective tyrosine kinase inhibitor of the EGFR gefitinib (also known as Iressa or ZD1839) to further investigate the role of EGFR in the invasion and growth of PC cells. We demonstrate that in the androgen-insensitive cell lines PC3 and DU145 this compound was able to decrease in vitro invasion of Matrigel by inhibiting EGFR autotransphosphorylation and subsequent PI3K activation. Gefitinib may be useful in the treatment of androgen-independent prostate cancer to limit not only the proliferation but also the invasion of these tumors.
Insights
Androgen receptor expression in prostate cancer cells reduces epidermal growth factor receptor (EGFR) signaling, decreasing cell invasion. This suggests potential therapeutic strategies targeting EGFR for androgen-independent prostate cancer.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- Androgen-sensitive prostate cancer cells exhibit reduced migration and invasion.
- The role of androgen receptors (AR) in modulating epidermal growth factor receptor (EGFR) signaling is not fully understood.
Purpose of the Study:
- To investigate how androgen receptor presence affects EGFR-mediated signaling pathways in prostate cancer cells.
- To evaluate the impact of AR on EGFR autophosphorylation and downstream PI3K/AKT pathway activation.
- To assess the therapeutic potential of EGFR inhibition in androgen-independent prostate cancer.
Main Methods:
- Immunoprecipitation studies to assess EGFR tyrosine phosphorylation.
- Measurement of PI3K activity in response to EGF stimulation.
- In vitro invasion assays using Matrigel.
- Treatment with gefitinib (EGFR inhibitor) and R1881 (androgen agonist).
Main Results:
- PC3 cells transfected with AR (PC3-AR) showed reduced EGF-induced EGFR tyrosine phosphorylation.
- EGF-stimulated PI3K activity was decreased in PC3-AR cells and further reduced by R1881.
- Gefitinib inhibited EGFR autotransphosphorylation and PI3K activation in androgen-insensitive cell lines (PC3, DU145), reducing in vitro invasion.
Conclusions:
- Androgen receptor expression confers a less malignant phenotype by interfering with EGFR signaling and reducing invasion.
- EGFR inhibition using gefitinib can decrease invasion and proliferation in androgen-independent prostate cancer.
- Targeting EGFR may be a viable strategy for treating advanced prostate cancer.
Related Concept Videos
Autocrine Signaling
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer Cell Migration through Invadopodia
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Enzymatic Cascade
Intracellular Signaling Affects Focal Adhesions
Some...

